This service funds the guideline directed management of eligible patients with abnormal uterine bleeding who would benefit from further investigation and/or treatment

This programme is available for people with type 2 diabetes who need to start insulin. The service provides funding for an initial consultation to start insulin and one follow up appointment.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

This programme provides funding for contraceptive consultation including administration of Depo Provera, and the insertion of contraceptive implants and IUDs to target populations. Vasectomies for priority men are funded under this programme.

This programme provides funding for Zoledronic acid infusions to patients with cancer related conditions who would benefit from this treatment. In most instances this infusion will be requested of general practice by the patient's oncologist. The infusion is to be provided in the community by the patient’s general practitioner.  

This service funds both education and practice costs for the management of ring pessaries

This programme provides funding for Zoledronic acid infusions for patients with osteoporosis who would benefit from treatment

This service funds the guideline directed management of eligible patients with abnormal uterine bleeding who would benefit from further investigation and/or treatment

The ED High Users Primary Care Reconnection Service is designed to re-establish (or establish) the connection of individuals and whanau with their primary care team, by providing funded consultations to develop and implement a comprehensive shared care plan alongside the relevant care partners to empower increased self-management and planned accessing of health services.

This programme is available for people with type 2 diabetes who need to start insulin. The service provides funding for an initial consultation to start insulin and one follow up appointment.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

This programme provides funding for contraceptive consultation including administration of Depo Provera, and the insertion of contraceptive implants and IUDs to target populations.